Albert Parés Selected Research

Ursodeoxycholic Acid (Urso)

11/2021	Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
1/2021	A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA.
1/2019	Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis.
1/2019	Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis.
1/2018	Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.
1/2018	A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis.
1/2018	Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response.
1/2017	Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial.
1/2017	Novel Treatment Strategies for Primary Biliary Cholangitis.
2/2016	Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Albert Parés Research Topics

Disease

32	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 12/2021 - 12/2002
20	Cholestasis 01/2022 - 11/2003
12	Liver Diseases (Liver Disease) 01/2022 - 06/2005
11	Osteoporosis 01/2022 - 03/2005
8	Pruritus (Itching) 11/2021 - 06/2004
7	Fibrosis (Cirrhosis) 01/2022 - 11/2003
4	Autoimmune Hepatitis 01/2022 - 12/2017
3	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 08/2013
3	Sclerosing Cholangitis 01/2019 - 07/2015
3	Neoplasms (Cancer) 01/2019 - 10/2009
2	Bone Resorption 01/2022 - 10/2003
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2019
2	Infections 01/2019 - 12/2002
2	Disease Progression 01/2018 - 12/2014
2	Ascites 07/2014 - 11/2003
2	Alcoholic Hepatitis 07/2014 - 01/2009
2	Hepatic Encephalopathy 07/2014 - 01/2009
2	Brain Diseases (Brain Disorder) 01/2009 - 11/2003
2	Hepatitis 07/2008 - 11/2004
1	End Stage Liver Disease 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2020
1	Alcoholism (Alcohol Abuse) 01/2018
1	Bone Diseases (Bone Disease) 01/2018
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2018
1	Hemochromatosis (Bronze Diabetes) 01/2018
1	Thyroiditis 01/2017
1	Thrombocytopenia (Thrombopenia) 02/2016
1	Intrahepatic Cholestasis of Pregnancy 01/2016
1	Granuloma 01/2016
1	Intrahepatic Cholestasis 01/2016
1	Cholangitis 01/2016
1	Jaundice (Icterus) 07/2014
1	Osteoarthritis 08/2013
1	Exanthema (Rash) 08/2013
1	Autoimmune Pancreatitis 01/2011
1	Traumatic Shock 01/2010

Drug/Important Bio-Agent (IBA)

20	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 11/2021 - 07/2003
18	BilirubinIBA 01/2022 - 11/2003
10	Alkaline PhosphataseIBA 12/2021 - 04/2005
8	obeticholic acidIBA 11/2021 - 01/2015
7	AlbuminsIBA 08/2014 - 11/2003
6	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 11/2010
6	Fibric Acids (Fibrates)IBA 11/2021 - 01/2015
6	AntibodiesIBA 01/2020 - 12/2002
5	BezafibrateIBA 11/2021 - 02/2014
5	Biomarkers (Surrogate Marker)IBA 02/2021 - 12/2014
5	Diphosphonates (Bisphosphonates)IBA 08/2014 - 10/2003
4	AutoantibodiesIBA 01/2020 - 11/2004
4	Immunoglobulin G (IgG)IBA 01/2020 - 11/2004
4	Vitamin D FDA LinkGeneric 01/2018 - 11/2010
3	Immunoglobulin M (IgM)IBA 01/2020 - 11/2004
3	IronIBA 01/2018 - 06/2011
3	Alendronate (Alendronate Sodium)FDA LinkGeneric 08/2014 - 10/2003
3	Pharmaceutical PreparationsIBA 02/2014 - 06/2012
3	CalciumIBA 06/2012 - 11/2010
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2021 - 02/2016
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2019 - 12/2017
2	Messenger RNA (mRNA)IBA 01/2016 - 01/2009
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2016
2	Transaminases (Aminotransferases)IBA 01/2015 - 08/2013
2	Ibandronic Acid (Boniva)FDA Link 08/2014 - 12/2013
2	Prothrombin (Factor II)IBA 07/2014 - 04/2005
1	Fenofibrate (CiL)FDA LinkGeneric 11/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2021
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 01/2020
1	CollagenIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	EpitopesIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	AutoantigensIBA 01/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019
1	AntigensIBA 01/2019
1	CateninsIBA 01/2018
1	Azathioprine (Imuran)FDA LinkGeneric 12/2017
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2017
1	Biological ProductsIBA 01/2017
1	tyramine-deoxysorbitolIBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	CholatesIBA 01/2016
1	AcidsIBA 04/2015
1	Alanine Transaminase (SGPT)IBA 04/2015
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 04/2015
1	CamptothecinIBA 12/2014
1	Sertraline (Zoloft)FDA LinkGeneric 08/2014
1	Rifampin (Rifampicin)FDA LinkGeneric 08/2014
1	VitaminsIBA 08/2014
1	Naltrexone (ReVia)FDA LinkGeneric 08/2014
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 08/2013
1	Glucosamine (Dona)IBA 08/2013
1	Cholic AcidIBA 08/2013
1	Lithocholic AcidIBA 08/2013
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2009

Therapy/Procedure

13	Therapeutics 11/2021 - 12/2013
9	Liver Transplantation 01/2022 - 11/2003
2	Aftercare (After-Treatment) 01/2022 - 08/2010
1	Transplantation 01/2020
1	Ligation 01/2016